vs
Broadridge Financial Solutions（BR）とSurgery Partners, Inc.（SGRY）の財務データ比較。上の社名をクリックして会社を切り替えられます
Broadridge Financial Solutionsの直近四半期売上が大きい（$1.7B vs $885.0M、Surgery Partners, Inc.の約1.9倍）。Broadridge Financial Solutionsの純利益率が高く（16.6% vs -1.7%、差は18.3%）。Surgery Partners, Inc.の前年同期比売上増加率が高い（2.4% vs -5.4%）。過去8四半期でSurgery Partners, Inc.の売上複合成長率が高い（11.1% vs 10.4%）
Broadridge Financial Solutions, Inc.はニューヨーク州レイクサクセスに本社を置く上場企業向けサービス・金融テクノロジー企業です。2007年にADPから分社して設立され、金融業界の顧客に対して株主委任状や年次報告書などの金融文書、バーチャル株主総会などの株主コミュニケーションソリューションを提供しています。
Surgery Partners, Inc.（NASDAQ：SGRY）傘下のUnited Surgical Partners International（USPI）は米国テキサス州ダラスに本拠を置く外来手術医療サービス企業で、1998年にドン・スティーンにより設立されました。複数の外来手術センターを運営し、米国各地の患者に質の高い効率的な外来外科医療を提供しています。
BR vs SGRY — 直接比較
損益計算書 — Q2 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $1.7B | $885.0M |
| 純利益 | $284.6M | $-15.0M |
| 粗利率 | 27.6% | — |
| 営業利益率 | 12.0% | 12.5% |
| 純利益率 | 16.6% | -1.7% |
| 売上前年比 | -5.4% | 2.4% |
| 純利益前年比 | 17.1% | 86.2% |
| EPS（希薄化後） | $2.42 | $-0.11 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.7B | $885.0M | ||
| Q3 25 | — | $821.5M | ||
| Q2 25 | $2.1B | $826.2M | ||
| Q1 25 | $1.8B | $776.0M | ||
| Q4 24 | $1.6B | $864.4M | ||
| Q3 24 | $1.4B | $770.4M | ||
| Q2 24 | $1.9B | $762.1M | ||
| Q1 24 | $1.7B | $717.4M |
| Q4 25 | $284.6M | $-15.0M | ||
| Q3 25 | — | $-22.7M | ||
| Q2 25 | $374.2M | $-2.5M | ||
| Q1 25 | $243.1M | $-37.7M | ||
| Q4 24 | $142.4M | $-108.5M | ||
| Q3 24 | $79.8M | $-31.7M | ||
| Q2 24 | $323.2M | $-15.5M | ||
| Q1 24 | $213.7M | $-12.4M |
| Q4 25 | 27.6% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 37.3% | — | ||
| Q1 25 | 31.8% | — | ||
| Q4 24 | 27.9% | — | ||
| Q3 24 | 24.5% | — | ||
| Q2 24 | 35.5% | — | ||
| Q1 24 | 31.2% | — |
| Q4 25 | 12.0% | 12.5% | ||
| Q3 25 | — | 12.9% | ||
| Q2 25 | 24.1% | 13.5% | ||
| Q1 25 | 19.0% | 8.0% | ||
| Q4 24 | 13.3% | 14.7% | ||
| Q3 24 | 9.4% | 7.9% | ||
| Q2 24 | 22.7% | 11.1% | ||
| Q1 24 | 17.5% | 10.6% |
| Q4 25 | 16.6% | -1.7% | ||
| Q3 25 | — | -2.8% | ||
| Q2 25 | 18.1% | -0.3% | ||
| Q1 25 | 13.4% | -4.9% | ||
| Q4 24 | 9.0% | -12.6% | ||
| Q3 24 | 5.6% | -4.1% | ||
| Q2 24 | 16.6% | -2.0% | ||
| Q1 24 | 12.4% | -1.7% |
| Q4 25 | $2.42 | $-0.11 | ||
| Q3 25 | — | $-0.18 | ||
| Q2 25 | $3.17 | $-0.02 | ||
| Q1 25 | $2.05 | $-0.30 | ||
| Q4 24 | $1.20 | $-0.86 | ||
| Q3 24 | $0.68 | $-0.25 | ||
| Q2 24 | $2.72 | $-0.12 | ||
| Q1 24 | $1.79 | $-0.10 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $371.5M | $239.9M |
| 総負債低いほど良い | $3.2B | $3.6B |
| 株主資本純資産 | $2.9B | $1.7B |
| 総資産 | $8.6B | $8.1B |
| 負債/資本比率低いほどレバレッジが低い | 1.10× | 2.10× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $371.5M | $239.9M | ||
| Q3 25 | — | $203.4M | ||
| Q2 25 | $562.2M | $250.1M | ||
| Q1 25 | $317.9M | $229.3M | ||
| Q4 24 | $290.6M | $269.5M | ||
| Q3 24 | $293.5M | $221.8M | ||
| Q2 24 | $305.2M | $213.5M | ||
| Q1 24 | $236.4M | $185.2M |
| Q4 25 | $3.2B | $3.6B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | $3.3B | $3.5B | ||
| Q1 25 | $3.4B | $3.4B | ||
| Q4 24 | $3.7B | $3.3B | ||
| Q3 24 | $3.6B | $3.1B | ||
| Q2 24 | $3.4B | $3.0B | ||
| Q1 24 | $3.5B | $2.8B |
| Q4 25 | $2.9B | $1.7B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | $2.7B | $1.7B | ||
| Q1 25 | $2.4B | $1.7B | ||
| Q4 24 | $2.2B | $1.8B | ||
| Q3 24 | $2.2B | $1.9B | ||
| Q2 24 | $2.2B | $2.0B | ||
| Q1 24 | $2.3B | $2.0B |
| Q4 25 | $8.6B | $8.1B | ||
| Q3 25 | — | $7.9B | ||
| Q2 25 | $8.5B | $8.0B | ||
| Q1 25 | $8.3B | $7.9B | ||
| Q4 24 | $8.2B | $7.9B | ||
| Q3 24 | $8.0B | $7.5B | ||
| Q2 24 | $8.2B | $7.5B | ||
| Q1 24 | $8.2B | $7.0B |
| Q4 25 | 1.10× | 2.10× | ||
| Q3 25 | — | 2.00× | ||
| Q2 25 | 1.22× | 1.98× | ||
| Q1 25 | 1.44× | 1.98× | ||
| Q4 24 | 1.64× | 1.83× | ||
| Q3 24 | 1.63× | 1.63× | ||
| Q2 24 | 1.55× | 1.56× | ||
| Q1 24 | 1.55× | 1.42× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | — | $103.4M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $90.6M |
| FCFマージンFCF / 売上 | — | 10.2% |
| 設備投資強度設備投資 / 売上 | — | 1.4% |
| キャッシュ転換率営業CF / 純利益 | — | — |
| 直近12ヶ月FCF直近4四半期 | — | $195.6M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | $103.4M | ||
| Q3 25 | — | $83.6M | ||
| Q2 25 | $699.7M | $81.3M | ||
| Q1 25 | $360.4M | $6.0M | ||
| Q4 24 | $236.7M | $111.4M | ||
| Q3 24 | $-125.5M | $65.2M | ||
| Q2 24 | $721.0M | $82.8M | ||
| Q1 24 | $207.4M | $40.7M |
| Q4 25 | — | $90.6M | ||
| Q3 25 | — | $63.8M | ||
| Q2 25 | $684.1M | $57.9M | ||
| Q1 25 | $348.9M | $-16.7M | ||
| Q4 24 | $227.9M | $89.1M | ||
| Q3 24 | $-133.4M | $45.0M | ||
| Q2 24 | $703.2M | $55.9M | ||
| Q1 24 | $184.6M | $19.7M |
| Q4 25 | — | 10.2% | ||
| Q3 25 | — | 7.8% | ||
| Q2 25 | 33.1% | 7.0% | ||
| Q1 25 | 19.3% | -2.2% | ||
| Q4 24 | 14.3% | 10.3% | ||
| Q3 24 | -9.4% | 5.8% | ||
| Q2 24 | 36.2% | 7.3% | ||
| Q1 24 | 10.7% | 2.7% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 2.4% | ||
| Q2 25 | 0.8% | 2.8% | ||
| Q1 25 | 0.6% | 2.9% | ||
| Q4 24 | 0.6% | 2.6% | ||
| Q3 24 | 0.6% | 2.6% | ||
| Q2 24 | 0.9% | 3.5% | ||
| Q1 24 | 1.3% | 2.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.87× | — | ||
| Q1 25 | 1.48× | — | ||
| Q4 24 | 1.66× | — | ||
| Q3 24 | -1.57× | — | ||
| Q2 24 | 2.23× | — | ||
| Q1 24 | 0.97× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
BR
| Recurring Fee Revenue Investor Communication Solutions | $589.5M | 34% |
| Recurring Fee Revenue Capital Markets | $300.9M | 18% |
| Recurring Fee Revenue Regulatory | $248.7M | 15% |
| Recurring Fee Revenue Customer Communications | $189.2M | 11% |
| Recurring Fee Revenue Wealth And Investment Management | $179.7M | 10% |
| Recurring Fee Revenue Data Driven Fund Solutions | $112.7M | 7% |
| Event Driven Revenue Mutual Funds | $51.4M | 3% |
| Event Driven Revenue Equity And Other | $39.2M | 2% |
| Global Technology And Operations | $7.5M | 0% |
SGRY
| Private Insurance | $460.5M | 52% |
| Government Revenue | $368.6M | 42% |
| Other | $19.8M | 2% |
| Self Pay Revenue | $19.6M | 2% |
| Other Patient Service Revenue Sources | $16.5M | 2% |
